Q-omics provides the consensus-scored SNORA36A profile across patient tissues and cancer cell-line models. SNORA36A expression is associated with patient survival in 16 of 34 cancer types, with the highest sampling consensus in BLCA. Additionally, SNORA36A RNA expression shows 4,584 significant pathway-activity associations, with the highest sampling consensus in ESCA. Together, these results highlight BLCA, and ESCA as cancer lineages where SNORA36A shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.